Pioglitazone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Pioglitazone. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Upper respiratory tract infection | 13.2% |
| Headache | 9.1% |
| Diabetes mellitus aggravated | 8.1% |
| Sinusitis | 6.3% |
| Myalgia | 5.4% |
| Tooth disorder | 5.3% |
| Pharyngitis | 5.1% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
ACTOS is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Source: FDA labeling via NIH DailyMed (set fd156adc…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.